|
|
Volumn 16, Issue 2, 2010, Pages 137-
|
|
New vaccine tailored to the weakened elderly immune system
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INFLUENZA VACCINE;
PLACEBO;
AGED;
ANTIBODY RESPONSE;
ANTIBODY TITER;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
DRUG APPROVAL;
DRUG DOSAGE FORM COMPARISON;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MEGADOSE;
FOOD AND DRUG ADMINISTRATION;
GERIATRIC CARE;
GERIATRIC PATIENT;
HUMAN;
IMMUNE SYSTEM;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A H1N1;
MAJOR CLINICAL STUDY;
MORTALITY;
NOTE;
POSTMARKETING SURVEILLANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESEARCH ETHICS;
SEASONAL VARIATION;
TREATMENT OUTCOME;
UNITED STATES;
VACCINATION;
AGED;
ANTIBODIES, VIRAL;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
PLACEBOS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 76249090000
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0210-137a Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
